773
CASE PRESENTATION: We report a patient with CF who developed recurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative-free tobramycin by inhalation, beginning at 16 months of age.
 a patient with CF: Subject; beginning at 16 months of age: Subject; 16 months: Subject.Age; recurrent eosinophilia and severe persistent bronchospasm: Effect; repeated administration of preservative-free tobramycin by inhalation: Treatment; CF: Treatment.Disorder; tobramycin: Treatment.Drug; inhalation: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient with CF: Subject; beginning at 16 months of age: Subject; 16 months: Subject.Age; recurrent eosinophilia and severe persistent bronchospasm: Effect; repeated administration of preservative-free tobramycin by inhalation: Treatment; CF: Treatment.Disorder; tobramycin: Treatment.Drug; inhalation: Treatment.Route